p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway

Danna Zheng1,2,3,4, Mei Tao2,3,4, Xudong Liang2,3,4

  • 1Zhejiang Chinese Medical University, Zhejiang, PR China.

Abstract

Insights

p66Shc protein inhibits autophagy and promotes apoptosis in kidney podocytes, contributing to diabetic kidney disease (DKD). Targeting p66Shc may offer a new therapeutic strategy for DKD.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic kidney disease (DKD) involves podocyte injury, with autophagy playing a crucial role.
  • p66Shc is implicated in oxidative stress and apoptosis, and its expression is elevated in DKD podocytes.
  • The precise mechanism linking p66Shc to podocyte autophagy and injury in DKD is not fully understood.

Purpose of the Study:

  • To investigate the molecular function of p66Shc in podocytes under high glucose conditions.
  • To explore the potential of targeting p66Shc as a therapeutic strategy for DKD.

Main Methods:

  • Utilized a streptozotocin-induced mouse model of diabetes.
  • Assessed kidney injury using histological staining and electron microscopy.
  • Evaluated podocyte apoptosis and autophagy markers via TUNEL, Annexin V/PI, immunofluorescence, and western blotting.
  • Measured reactive oxygen species (ROS) levels using DHE/ET fluorescence.

Main Results:

  • Diabetic mice exhibited increased markers of kidney injury and p66Shc expression.
  • High glucose reduced podocyte viability; p66Shc overexpression exacerbated apoptosis.
  • p66Shc knockdown enhanced autophagy, while overexpression inhibited it by downregulating PTEN and upregulating mTOR signaling.
  • Inhibition of the Notch pathway with DAPT reduced p66Shc expression.

Conclusions:

  • p66Shc inhibits podocyte autophagy and induces apoptosis via the Notch-PTEN-PI3K/Akt/mTOR pathway in high glucose conditions.
  • These findings highlight p66Shc as a potential therapeutic target for DKD.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.1K